Number 5: The FDA has approved Pavblu (aflibercept-ayyh), the fifth biosimilar referencing Eylea (aflibercept).1 The new ...

Amgen’s Pavblu (aflibercept-ayyh) is the fifth biosimilar referencing Eylea (aflibercept) to be approved for American ...

INCHEON, South Korea and CAMBRIDGE, MA, USA I September 20, 2024 I Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European ...

OPUVIZ has been recommended for approval in adult patients for the treatment of neovascular age related macular degeneration, visual impairment due to macular oedema secondary to retinal vein ...

Diabetic Macular Edema Market valuation is set to cross USD 4,642.9 million by 2034, at a CAGR of 1.2% through 2034.

A total of 134 subjects with MacTel that had at least two visits with OCT scans were collected. 14 subjects were excluded due ...

Cystoid macular edema risk is lower for those using prostaglandin analogs than those using any other common class of glaucoma topical.

REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

RVO refers to blockage of veins in the retina, which is the light-sensitive membrane in the back of your eye. This blockage may result in damage to the macula just described. Vabysmo is a ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and age-related macular degeneration. The ...